African countries urged to prioritize investment in infectious diseases amid COVID-19

ETHIOPIA – A new report by the United Nations Economic Commission for Africa (ECA) has shown that Africa can prevent needless loss of lives and save millions of dollars each year by prioritizing investment in infectious diseases, which pose a significant public health burden across the continent other than COVID-19. The entry of COVID-19 has already thrown a wrench into the vaccine administration cycle for a number of infectious diseases, putting many more people at the risk of death from other causes, while COVID-19 could indirectly increase the burden of…

Read More

Glenmark’s innovative nasal spray gets EU marketing approval

INDIA – Glenmark Pharmaceuticals has announced that its fixed-dose combination nasal spray, Ryaltris, has received marketing approval in 13 countries across the EU and the UK, bolstering the company’s respiratory therapy line. Glenmark is a global research-led pharmaceutical company with operations in over 50 countries and a presence in generics, specialty, and over-the-counter (OTC) businesses. Glenmark’s primary therapeutic focus areas include respiratory, dermatology, and oncology. In terms of revenue, it is ranked among the top 80 Pharma & Biotech companies in the world. Ryaltris is a combination of antihistamine plus…

Read More

KUTRRH gets 20,000-liter oxygen tank support from World Bank

KENYA – The MOH-Kenya has officially commissioned a 20,000-liter liquid oxygen tank donated by the Ministry of Health through the World Bank, in support o the hospital’s front-line role in combating COVID 19. Dr. Anne Nganga, Project Manager for the COVID 19 Emergency Response Project, represented the Ministry and stated that the Government of Kenya will continue to support all institutions involved in the COVID 19 fight. Ms. Gladys Ogallo, KUTRRH Board representative, expressed gratitude to the MOH. She thanked the Ministry for their attention to the Hospital and assistance…

Read More

Zydus Cadila’s needle-free COVID-19 vaccine gets emergency use approval in India

INDIA – Zydus Cadila indigenously developed needle-free COVID-19 vaccine (ZyCOV-D) has received an emergency use authorization from the Drugs Controller General of India (DCGI) and it will be administered to people aged 12 years and above. ZyCoV-D is a first-of-its-kind DNA vaccine developed in collaboration with the Department of Biotechnology that produces the spike protein of the SARS-CoV-2 to elicit an immune response, which is critical for disease protection and viral clearance. As an intradermal vaccine, it must be applied with a ‘needle-free injector,’ according to the manufacturer, which will…

Read More

Medanta hospitals owner files for IPO at India’s securities bourse

INDIA – Global Health Private Ltd, which operates and manages hospitals across India under the Medanta brand has launched an initial public offering with SEBI to raise money from the market. The IPO consists of a new issue of equity shares worth US$ 6.73 million (Rs 500 crore) and an offer for sale of up to 48.44 million shares by the company’s promoters and shareholders — 43.34 million shares by Anant Investments and up to 5.1 million shares by Sunil Sachdev. Global Health is one of North and East India’s…

Read More

Sanofi urged to handover abandoned m-RNA vaccines to SA’s tech transfer hub

SOUTH AFRICA – Following news that French pharmaceutical corporation Sanofi will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) has urged the corporation to transfer the technology and know-how for the vaccine to the World Health Organization (WHO)-led COVID-19 mRNA vaccine technology transfer hub in South Africa. “It’s unconscionable for Sanofi to let a promising vaccine candidate gather dust on its shelves simply because it won’t be lucrative for them, when they have an opportunity to put this research to lifesaving use by transferring their know-how to…

Read More